Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

66.18 0.40 −0.60%
Market cap
$32.1B
P/E
50.5×
Fwd P/E
31.0×
Dividend yield
0.53%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

35.15 39.60 45.12 51.22
P/S ratio
3.61 3.74 3.45 3.01
P/FCF ratio
26.53 24.10 23.00 20.49
P/Operating CF
50.76 59.07 87.82 64.03
P/B ratio
1.66 1.76 1.66 1.51
EV/Sales
3.93 4.04 3.74 3.31
EV/EBITDA
15.31 16.46 15.67 13.13
EV/FCF
28.87 26.04 24.93 22.53
Current Ratio
2.12 2.12 2.20 2.09
Net Debt/EBITDA
4.89 4.85 4.93 4.06
Debt/Equity
0.21 0.22 0.21 0.22
Earnings Yield
2.85% 2.53% 2.22% 1.95%
Free Cash Flow Yield
3.77% 4.15% 4.35% 4.88%
Free Cash Flow per Share
1.09 0.93 0.47 0.76
Book value per Share
44.79 44.68 45.43 44.37
Free Cash Flow
540.00 457.00 227.00 370.00
EV/EBIT
27.73 30.88 33.60 37.89
Other line items

Show all line items

Columns are period end dates